4.03
price down icon0.50%   -0.01
after-market After Hours: 3.92 -0.11 -2.73%
loading
Cargo Therapeutics Inc stock is traded at $4.03, with a volume of 1.51M. It is down -0.50% in the last 24 hours and up +1.01% over the past month.
See More
Previous Close:
$4.02
Open:
$3.9
24h Volume:
1.51M
Relative Volume:
1.52
Market Cap:
$185.13M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.1239
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
-1.72%
1M Performance:
+1.01%
6M Performance:
-78.54%
1Y Performance:
-81.39%
1-Day Range:
Value
$3.61
$4.04
1-Week Range:
Value
$3.61
$4.25
52-Week Range:
Value
$3.00
$25.45

Cargo Therapeutics Inc Stock (CRGX) Company Profile

Name
Name
Cargo Therapeutics Inc
Name
Phone
650-499-8950
Name
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2025-03-31
Name
Latest SEC Filings
Name
CRGX's Discussions on Twitter

Compare CRGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
CRGX
Cargo Therapeutics Inc
4.03 185.13M 0 -147.71M -127.89M -3.5857
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
474.56 121.88B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
572.78 62.69B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
550.00 32.85B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.95 28.75B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
220.54 25.69B 3.81B -644.79M -669.77M -6.24

Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-30-25 Downgrade Chardan Capital Markets Buy → Neutral
Jan-30-25 Downgrade H.C. Wainwright Buy → Neutral
Jan-30-25 Downgrade JP Morgan Overweight → Underweight
Jan-30-25 Downgrade Jefferies Buy → Hold
Jan-30-25 Downgrade Piper Sandler Overweight → Neutral
Jan-30-25 Downgrade Truist Buy → Hold
Jan-30-25 Downgrade William Blair Outperform → Mkt Perform
Nov-26-24 Initiated William Blair Outperform
Jul-22-24 Initiated H.C. Wainwright Buy
Jul-08-24 Initiated Chardan Capital Markets Buy
Jun-27-24 Initiated Piper Sandler Overweight
Dec-05-23 Initiated JP Morgan Overweight
Dec-05-23 Initiated Jefferies Buy
Dec-05-23 Initiated TD Cowen Outperform
Dec-05-23 Initiated Truist Buy
View All

Cargo Therapeutics Inc Stock (CRGX) Latest News

pulisher
Apr 04, 2025

Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace

Apr 04, 2025
pulisher
Mar 31, 2025

Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World

Mar 31, 2025
pulisher
Mar 28, 2025

Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World

Mar 28, 2025
pulisher
Mar 27, 2025

Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Mar 27, 2025
pulisher
Mar 21, 2025

Biotech company based in Peninsula laying off 90% of staff - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com

Mar 20, 2025
pulisher
Mar 20, 2025

California-Based Biotech Therapeutics Firm Lays Off 90% of Workforce - NewsBreak: Local News & Alerts

Mar 20, 2025
pulisher
Mar 20, 2025

Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech

Mar 20, 2025
pulisher
Mar 19, 2025

Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle

Mar 19, 2025
pulisher
Mar 19, 2025

Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff - SFGATE

Mar 19, 2025
pulisher
Mar 19, 2025

CARGO THERAPEUTICS Earnings Preview: Recent $CRGX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail

Mar 19, 2025
pulisher
Mar 19, 2025

CARGO Stock Surges 19% Pre-Market After Suspending Development, Cutting 90% of Workforce - GuruFocus.com

Mar 19, 2025
pulisher
Mar 19, 2025

Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit - Endpoints News

Mar 19, 2025
pulisher
Mar 19, 2025

Cargo shelves cell therapy research, lays off more staff - BioPharma Dive

Mar 19, 2025
pulisher
Mar 19, 2025

Cargo Lays Off 90% of Staff and Stops Development Work - BioSpace

Mar 19, 2025
pulisher
Mar 19, 2025

CARGO Therapeutics (CRGX) Stock Climbs In Pre-Hour Market - Stocks Telegraph

Mar 19, 2025
pulisher
Mar 19, 2025

After-hours movers: Gilead Sciences, HealthEquity, CARGO Therapeutics and more - Investing.com

Mar 19, 2025
pulisher
Mar 18, 2025

Once-high-flying Cargo Therapeutics looks to ditch remaining work as CEO exitsSan Francisco Business Times - The Business Journals

Mar 18, 2025
pulisher
Mar 18, 2025

Cargo Therapeutics provides corporate update -March 18, 2025 at 05:43 pm EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics halts development, cuts 90% of staff By Investing.com - Investing.com Australia

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics rises after hours on workforce reduction - MSN

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics halts development, cuts 90% of staff - Investing.com

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics Announces Major Workforce Reduction - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

Cargo suspends CRG-023 and allogeneic platform, reduces workforce by 90% - TipRanks

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics Suspends Development of CRG-023 and Allogeneic Platform, Appoints Interim CEO and Reduces Workforce by 90% - Nasdaq

Mar 18, 2025
pulisher
Mar 18, 2025

CARGO Therapeutics Provides Corporate Update - The Bakersfield Californian

Mar 18, 2025
pulisher
Mar 18, 2025

Major Shakeup: CARGO Therapeutics Ends All Programs Despite $368M Cash Position - StockTitan

Mar 18, 2025
pulisher
Mar 18, 2025

William Blair Expects Weaker Earnings for CARGO Therapeutics - Defense World

Mar 18, 2025
pulisher
Mar 15, 2025

CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Recommendation of “Reduce” from Analysts - Defense World

Mar 15, 2025
pulisher
Mar 13, 2025

CARGO Therapeutics, Inc.: Hold Rating Amidst Developmental Stagnation and Future Prospects - TipRanks

Mar 13, 2025
pulisher
Mar 13, 2025

CARGO Therapeutics (CRGX) to Release Quarterly Earnings on Thursday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

CARGO Therapeutics Inc. (CRGX) reports earnings - Quartz

Mar 12, 2025
pulisher
Mar 10, 2025

Levi & Korsinsky Reminds Shareholders of an Investigation into CARGO Therapeutics, Inc. (CRGX) Regarding Potential Securities Fraud Allegations - ACCESS Newswire

Mar 10, 2025
pulisher
Mar 04, 2025

Airline Stocks To Research – March 2nd - Defense World

Mar 04, 2025
pulisher
Mar 03, 2025

Checkpoint Therapeutics: Pivoting From Approval To Gutsy Next Shot On Goal (NASDAQ:CKPT) - Seeking Alpha

Mar 03, 2025
pulisher
Mar 03, 2025

CARGO Therapeutics: A Gutted CAR T Player Trying To Find New Direction (NASDAQ:CRGX) - Seeking Alpha

Mar 03, 2025
pulisher
Mar 02, 2025

Lost Money on CARGO Therapeutics, Inc.(CRGX)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire

Mar 02, 2025
pulisher
Feb 28, 2025

Airline Stocks To Research – February 26th - Defense World

Feb 28, 2025
pulisher
Feb 27, 2025

CARGO Therapeutics Discloses Strategic Corporate Presentation via SEC Filing - Defense World

Feb 27, 2025
pulisher
Feb 26, 2025

Alector Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Feb 26, 2025
pulisher
Feb 25, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CARGO Therapeutics, IncCRGX - PR Newswire

Feb 25, 2025

Cargo Therapeutics Inc Stock (CRGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Cargo Therapeutics Inc Stock (CRGX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Chapman Gina
President & CEO
Sep 19 '24
Option Exercise
5.03
2,975
14,964
106,880
Chapman Gina
President & CEO
Sep 18 '24
Sale
25.09
7,166
179,775
103,905
Chapman Gina
President & CEO
Sep 19 '24
Sale
25.03
2,975
74,457
103,905
Radhakrishnan Anup
Chief Financial Officer
Sep 18 '24
Option Exercise
5.03
1,600
8,048
8,046
Radhakrishnan Anup
Chief Financial Officer
Sep 18 '24
Sale
25.28
1,600
40,452
6,446
$60.29
price down icon 0.56%
$68.09
price down icon 1.56%
$17.32
price down icon 0.43%
$31.03
price down icon 0.26%
$86.82
price down icon 1.40%
biotechnology ONC
$220.54
price down icon 7.63%
Cap:     |  Volume (24h):